ProKidney Corp. to Participate in September Healthcare Conferences

Winston-Salem, N.C. — August 27, 2025 — Leads & Copy — ProKidney Corp. (Nasdaq: PROK) will participate in two healthcare conferences in September. Senior management will attend the Citi Biopharma Back to School Conference in Boston on Sept. 3 at 10:30 a.m. ET and the Morgan Stanley Global Healthcare Conference in New York on Sept. 8 at 7:00 a.m. ET.

Live webcasts will be available through the “Events” section of ProKidney’s website.

ProKidney, founded in 2015, focuses on chronic kidney disease (CKD) treatment through cellular therapy innovations. Their lead product, rilparencel (REACT®), is in Phase 3 trials.

Investor Contacts: Ethan Holdaway, Ethan.Holdaway@prokidney.com; Daniel Ferry, Daniel@lifesciadvisors.com.

Source: ProKidney Corp.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.